Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myeloma

Controlled Clinical Trials

Volumn 17, Issue 5, 1996, Pages 372-386

  Hjorth, Martin ^a   Holmberg, Erik ^b   Rödjer, Stig ^b   Taube, Adam ^b   Westin, Jan ^b  

^a Lidkoping Hospital   (Sweden)

^b NONE

Author keywords

controlled clinical trials; multicenter studies; multiple myeloma; patient accrual; physicians' attitudes; questionnaires

Indexed keywords

ALPHA2B INTERFERON; MELPHALAN; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON;

ARTICLE; CLINICAL TRIAL; ETHICS; HUMAN; INTERPERSONAL COMMUNICATION; MULTICENTER STUDY; MYELOMA; ORGANIZATION; PHYSICIAN; QUALITY OF LIFE; QUESTIONNAIRE; SUBCUTANEOUS DRUG ADMINISTRATION;

ATTITUDE OF HEALTH PERSONNEL; COMMUNICATION; CONTROLLED CLINICAL TRIALS; DECISION MAKING; DENMARK; DRUG THERAPY, COMBINATION; ETHICS, MEDICAL; FEMALE; HUMANS; INTERINSTITUTIONAL RELATIONS; MALE; MIDDLE AGED; MOTIVATION; MULTICENTER STUDIES; MULTIPLE MYELOMA; NORWAY; PATIENT SELECTION; PHYSICIANS; QUALITY OF LIFE; SWEDEN; WORKLOAD;

EID: 0030271630     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(96)00022-0     Document Type: Article

References (20)

1. 1. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: Literature summary and annotated bibliography. Control Clin Trials. 1987;8:6S-30S.
2. 2. Friedman MA, Cain DF. National Cancer Institute Sponsored Cooperative Clinical Trials. Cancer. 1990;65(Suppl):2376-2382.
3. 3. American Medical Association Council on Scientific Affairs. Viability of cancer clinical research: patient accrual, coverage, and reimbursement. JNCI 1991; 83:254-259.
4. 4. Johansen MA, Mayer DK, Hoover HC. Obstacles in implementing cancer clinical trials. Semin Oncol Nurs. 1991;7:260-267.
5. 5. Martin JF, Henderson WG, Zacharski LR, et al. Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies. Am J Clin Oncol. 1984;7:173-182.
6. 6. Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol. 1994;12:1796-1805.
7. 7. Hunter CP, Frelick RW, Feldman AR, et al. Selection factors in clinical trials: Results from the Community Clinical Oncology Program physician's patient log. Cancer Treat Rep. 1987;71:559-565.
8. 8. Fisher WB, Cohen SJ, Hammond MK, Turner S, Loehrer PJ. Clinical trials in cancer therapy: efforts to improve patient enrollment by community oncologists. Med Pediatr Oncol 1991;19:165-168.
9. 9. Cassileth BR, Lusk EJ, Miller DS. Attitudes toward clinical trials among patients and the public. JAMA. 1982;248:968-970.
10. 10. The Nordic Myeloma Study Group. Interferon-alfa-2b added to melphalan-prednisone for initial and maintenance treatment in multiple myeloma: a randomized, controlled trial. Ann Intern Med. 1996;124:212-222.
11. 11. Hjorth M, Holmberg E, Rödjer S, Taube A, Westin J. Patient accrual and quality of participation in a multicenter study on myeloma - a comparison between major and minor participating centers. Br J Haematol. 1995;91:109-115.
12. 12. Hjorth M, Holmberg E, Rödjer S, Westin J. Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. Br J Haematol. 1992;80:55-61.
13. 13. Benson AB, III, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center Study. J Clin Oncol. 1991;9:2067-2075.
14. 14. Taylor KM, Margolese RS, Colin SL. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med. 1984;310:1363-1367.
15. 15. Taylor KM, Kelner M. Interpreting physician participation in randomized clinical trials: the Physician Orientation Profile. J Health Soc Behav. 1987;28:389-400.
16. 16. Pocock SJ. Clinical Trials: A Practical Approach. John Wiley and Sons, New York, 1983.
17. 17. Shuster JJ, Krischer JP, Boyett JM. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. I. A general overview. Am J Pediatr Hematol/ Oncol. 1985;7:57-63.
18. 18. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979;300: 1242-1245.
19. 19. Schafer A. The ethics of the randomized clinical trial. N Engl J Med. 1982;307:719-724.
20. 20. Farrar WB. Clinical trials. Access and reimbursement. Cancer. 1991;67:1779-1782.